Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: Evaluated by optical coherence tomography

European Heart Journal

Volumn 28, Issue 8, 2007, Pages 961-967

  Matsumoto, Daisuke ^a   Shite, Junya ^a   Shinke, Toshiro ^a   Otake, Hiromasa ^a   Tanino, Yusuke ^a   Ogasawara, Daisuke ^a   Sawada, Takahiro ^a   Paredes, Oscar Luis ^a   Hirata, Ken Ichi ^a   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Malapposition; Neointima; Optical coherence tomography; Sirolimus eluting stents

Indexed keywords

ACETYLSALICYLIC ACID; RAPAMYCIN; TICLOPIDINE;

ACUTE CORONARY SYNDROME; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; DIRECTIONAL ATHERECTOMY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INTIMA; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL;

AGED; ASPIRIN; BALLOON DILATATION; CELL PROLIFERATION; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; SIROLIMUS; STENTS; TICLOPIDINE; TOMOGRAPHY, OPTICAL COHERENCE; TUNICA INTIMA;

EID: 34548329438     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl413     Document Type: Article

References (22)

1. Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 2004;364:583-591.
2. McFadden EP, Stabile E, Regar E, Cheneau E, Ong ATL, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521.
3. Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, Ho KK, Cohen DJ, Garcia LA, Cutlip DE, Carrozza JP Jr. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004;109:1930-1932.
4. Orlic D, Bonizzoni E, Stankovic G, Airoldi F, Chieffo A, Corvaja N, Sangiorgi G, Ferraro M, Briguori C, Montorfano M, Carlino M, Colombo A. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results. J Am Coll Cardiol 2004;43:1154-1160.
5. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AHM, Bonneau HN, Leon MB, Moses JW, Yock PG, Honda Y, Kuntz RE, Fitzgerald PJ, for the SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation. Serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 2004;43:1959-1963.
6. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, Mintz GS, Nagata S. Incomplete neointimal coverage of sirolimus-eluting stents angioscopic findings. J Am Coll Cardiol 2006;47:2108-2111.
7. Jang IK, Bouma BE, Kang DH, Park SJ, Park SW, Seong KB, Choi KB, Shishkov M, Schlendorf K, Pomerantsev E, Houser SL, Aretz T, Tearney GJ. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 2002;39:604-609.
8. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Sukmawan R, Sadahira Y, Yoshida K. Visualization of neointima formation by optical coherence tomography. Int Heart J 2005;46:1133-1136.
9. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, Shishkov M, Houser S, Aretz HT, Halpern EF, Bouma BE. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005;111:1551-1555.
10. Shite J, Matsumoto D, Yokoyama M. Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography. Eur Heart J 2006;27:1389.
11. Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, Melby S, Berger PB. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003;42:234-240.
12. Ueda Y, Nanto S, Komamura K, Kodama K. Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol 1994;23:341-346.
13. Shah VM, Mintz GS, Apple S, Weissman NJ. Background incidence of late malapposition after bare-metal stent implantation. Circulation 2002;106:1753-1755.
14. Mintz GS, Shah VM, Weissman NJ. Regional remodeling as the cause of late stent malapposition. Circulation 2003;107:2660-2663.
15. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 2004;109:881-886.
16. Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, Leon MB, Moses JW, Bonneau HN, Fitzgerald PJ. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 2005;46:1002-1005.
17. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005;112:270-278.
18. Sousa JE, Costa MA, Abizaid A, Sousa AGMR, Feres F, Mattos LA, Centemero M, Maldonado G, Abizaid AS, Pinto I, Falotico R, Jaeger J, Popma JJ, Serruys PW. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003;107:24-27.
19. Degertekin M, Regar E, Tanabe K, Smits PC, Giessen WJ, Carlier SG, Feyter P, Vos J, Foley DP, Ligthart JMR, Popma JJ, Serruys PW. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol 2003;41:184-189.
20. Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, Mugge A, Pede FD, Fullgraf D, Aengevaeren W, Spedicato L, Popma JJ. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005;111:2107-2111.
21. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Kang DH, Halpen EF, Tearney GJ. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640-1645.
22. Sousa JE, Costa MA, Farb A, Abizaid A, Sousa A, Seixas AC, Silva LM, Feres F, Pinto I, Mattos LA, Virmani R. Vascular healing 4 years after the implantation of sirolimus-eluting stent in humans. Circulation 2004;110:e5-e6.